StockData
Zenas BioPharma, Inc. logo

Zenas BioPharma, Inc. (ZBIO) stock

ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$26.42−1.33 (-4.79%)

Close on Nov 18, 2026Market cap $1.72BP/E –Yield –

Zenas BioPharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Zenas BioPharma

Zenas BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Zenas BioPharma figures

See a number that looks wrong?